Review of NHS mergers: CMA29
- Competition and Markets Authority
- Part of:
- CMA mergers guidance, How the CMA investigates competition and consumer issues, Competition law, and Mergers
- First published:
- 31 July 2014
Provides guidance on the CMA’s procedure and approach to its assessment when reviewing mergers involving a public provider of the National Health Service (NHS).
Ref: CMA29 PDF, 684KB, 62 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This guidance is for advisers of organisations providing NHS services, the organisations themselves and other interested parties in their interactions with the CMA in relation to NHS mergers.
The guidance explains:
- the NHS merger review process
- procedures including Monitor’s involvement
- how the CMA assesses an NHS merger
- where it finds a competition concern that would lead to worse outcomes for patients and/or commissioners, and how it takes into account any benefits arising from the merger
The CMA and Monitor have also published a short guide for managers of NHS providers.
Read the responses to the consultation on this guidance and the CMA’s summary and views on these.
Published: 31 July 2014